These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 3156648

  • 1. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G, Smith GM.
    Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
    [Abstract] [Full Text] [Related]

  • 2. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
    Menys VC, Davies JA.
    Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo.
    Booth RF, Honey AC, Lad N, Tuffin DP, Wade PJ.
    Br J Pharmacol; 1989 Feb; 96(2):395-405. PubMed ID: 2522336
    [Abstract] [Full Text] [Related]

  • 4. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA, Naka M, Masuda A, Oatis JE, Okwu AK, Mais DE, Saussy DL, Halushka PV.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Feb; 21A():331-7. PubMed ID: 1825565
    [No Abstract] [Full Text] [Related]

  • 5. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets.
    Halushka PV, Mais DE, Garvin M.
    Eur J Pharmacol; 1986 Nov 12; 131(1):49-54. PubMed ID: 3816947
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP, Watts IS.
    Br J Pharmacol; 1982 Apr 12; 75(4):623-31. PubMed ID: 6802211
    [Abstract] [Full Text] [Related]

  • 7. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.
    Mayeux PR, Morton HE, Gillard J, Lord A, Morinelli TA, Boehm A, Mais DE, Halushka PV.
    Biochem Biophys Res Commun; 1988 Dec 15; 157(2):733-9. PubMed ID: 2974286
    [Abstract] [Full Text] [Related]

  • 8. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS, Wharton KA, White BP, Lumley P.
    Br J Pharmacol; 1991 Feb 15; 102(2):497-505. PubMed ID: 1826620
    [Abstract] [Full Text] [Related]

  • 9. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B.
    Biosci Rep; 1983 Sep 15; 3(9):791-813. PubMed ID: 6315101
    [No Abstract] [Full Text] [Related]

  • 10. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ.
    Br J Clin Pharmacol; 1983 Sep 15; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [Abstract] [Full Text] [Related]

  • 11. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes.
    Mais DE, Saussy DL, Magee DE, Williams CM.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Sep 15; 21A():347-50. PubMed ID: 1825567
    [No Abstract] [Full Text] [Related]

  • 12. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
    Johnson GJ, Dunlop PC, Leis LA, From AH.
    Circ Res; 1988 Mar 15; 62(3):494-505. PubMed ID: 2449295
    [Abstract] [Full Text] [Related]

  • 13. Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.
    Aksoy MO, Harakal C, Smith JB, Stewart GJ, Zerweck CR.
    Br J Pharmacol; 1990 Mar 15; 99(3):461-6. PubMed ID: 2110015
    [Abstract] [Full Text] [Related]

  • 14. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA, Jones RL, Peesapati V, Will SG, Wilson NH.
    Br J Pharmacol; 1985 Mar 15; 84(3):595-607. PubMed ID: 2580580
    [Abstract] [Full Text] [Related]

  • 15. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.
    O'Keefe EH, Liu EC, Greenberg R, Ogletree ML.
    Prostaglandins; 1985 May 15; 29(5):785-97. PubMed ID: 3925501
    [Abstract] [Full Text] [Related]

  • 16. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P, Ambrosio G, Villari B, Ragni M, Focaccio A, Pace L, de Clerk F, Condorelli M, Chiariello M.
    J Am Coll Cardiol; 1993 Feb 15; 21(2):493-501. PubMed ID: 8426016
    [Abstract] [Full Text] [Related]

  • 17. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H, Stegmeier K.
    Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat.
    Kato T, Iwama Y, Okumura K, Hashimoto H, Ito T, Satake T.
    Hypertension; 1990 May 01; 15(5):475-81. PubMed ID: 2332238
    [Abstract] [Full Text] [Related]

  • 19. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
    Pollock WK, Armstrong RA, Brydon LJ, Jones RL, MacIntyre DE.
    Biochem J; 1984 May 01; 219(3):833-42. PubMed ID: 6234886
    [Abstract] [Full Text] [Related]

  • 20. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P, Rosolowsky M, Yao SK, McNatt J, De Clerck F, Buja LM, Willerson JT.
    J Clin Invest; 1990 Oct 01; 86(4):1095-102. PubMed ID: 2145320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.